DRGYX | RMFEX | DRGYX / RMFEX | |
Total Expense Ratio | 0.64 | 0.62 | 103% |
Annual Report Gross Expense Ratio | 0.64 | 0.62 | 103% |
Fund Existence | 12 years | 23 years | - |
Gain YTD | 6.774 | 10.243 | 66% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 250 | 400,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 8.56B | 108B | 8% |
Annual Yield % from dividends | 1.12 | 1.51 | 74% |
Returns for 1 year | 6.11 | 9.89 | 62% |
Returns for 3 years | 19.32 | 27.52 | 70% |
Returns for 5 years | 49.13 | 58.94 | 83% |
Returns for 10 years | 24.99 | 86.68 | 29% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
UPV | 75.97 | 1.57 | +2.11% |
ProShares Ultra FTSE Europe | |||
FEX | 111.91 | 1.63 | +1.48% |
First Trust Large Cap Core AlphaDEX® ETF | |||
SBIO | 33.15 | 0.46 | +1.39% |
ALPS Medical Breakthroughs ETF | |||
NJAN | 51.57 | 0.46 | +0.89% |
Innovator Growth-100 Pwr Buff ETF™ Jan | |||
QBUF | 28.00 | 0.01 | +0.04% |
Innovator Nasdaq-100 10 Buffr ETF - Qt |